rs2353005
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001098633.4(AKT1S1):c.*412C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.103 in 158,598 control chromosomes in the GnomAD database, including 1,018 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.10 ( 947 hom., cov: 33)
Exomes 𝑓: 0.12 ( 71 hom. )
Consequence
AKT1S1
NM_001098633.4 3_prime_UTR
NM_001098633.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.776
Publications
19 publications found
Genes affected
AKT1S1 (HGNC:28426): (AKT1 substrate 1) AKT1S1 is a proline-rich substrate of AKT (MIM 164730) that binds 14-3-3 protein (see YWHAH, MIM 113508) when phosphorylated (Kovacina et al., 2003 [PubMed 12524439]).[supplied by OMIM, Mar 2008]
PNKP (HGNC:9154): (polynucleotide kinase 3'-phosphatase) This locus represents a gene involved in DNA repair. In response to ionizing radiation or oxidative damage, the protein encoded by this locus catalyzes 5' phosphorylation and 3' dephosphorylation of nucleic acids. Mutations at this locus have been associated with microcephaly, seizures, and developmental delay.[provided by RefSeq, Sep 2010]
PNKP Gene-Disease associations (from GenCC):
- ataxia - oculomotor apraxia type 4Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine
- microcephaly, seizures, and developmental delayInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Charcot-Marie-Tooth disease type 2B2Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.141 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AKT1S1 | NM_001098633.4 | c.*412C>T | 3_prime_UTR_variant | Exon 5 of 5 | ENST00000344175.10 | NP_001092103.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AKT1S1 | ENST00000344175.10 | c.*412C>T | 3_prime_UTR_variant | Exon 5 of 5 | 3 | NM_001098633.4 | ENSP00000341698.5 |
Frequencies
GnomAD3 genomes AF: 0.102 AC: 15487AN: 152190Hom.: 949 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
15487
AN:
152190
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.125 AC: 786AN: 6290Hom.: 71 Cov.: 0 AF XY: 0.123 AC XY: 405AN XY: 3284 show subpopulations
GnomAD4 exome
AF:
AC:
786
AN:
6290
Hom.:
Cov.:
0
AF XY:
AC XY:
405
AN XY:
3284
show subpopulations
African (AFR)
AF:
AC:
12
AN:
238
American (AMR)
AF:
AC:
7
AN:
126
Ashkenazi Jewish (ASJ)
AF:
AC:
27
AN:
230
East Asian (EAS)
AF:
AC:
30
AN:
242
South Asian (SAS)
AF:
AC:
55
AN:
614
European-Finnish (FIN)
AF:
AC:
49
AN:
478
Middle Eastern (MID)
AF:
AC:
0
AN:
30
European-Non Finnish (NFE)
AF:
AC:
562
AN:
3956
Other (OTH)
AF:
AC:
44
AN:
376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
34
68
102
136
170
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.102 AC: 15477AN: 152308Hom.: 947 Cov.: 33 AF XY: 0.0991 AC XY: 7382AN XY: 74476 show subpopulations
GnomAD4 genome
AF:
AC:
15477
AN:
152308
Hom.:
Cov.:
33
AF XY:
AC XY:
7382
AN XY:
74476
show subpopulations
African (AFR)
AF:
AC:
1512
AN:
41576
American (AMR)
AF:
AC:
1413
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
384
AN:
3472
East Asian (EAS)
AF:
AC:
630
AN:
5178
South Asian (SAS)
AF:
AC:
444
AN:
4830
European-Finnish (FIN)
AF:
AC:
943
AN:
10618
Middle Eastern (MID)
AF:
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9774
AN:
68014
Other (OTH)
AF:
AC:
235
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
725
1451
2176
2902
3627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
318
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.